Rani Therapeutics Holdings Inc.
Organization details
- Legal name
- Rani Therapeutics Holdings Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- California
- Headquarters city
- SAN Jose
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- RANI
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001856725
- EIN
- 86-3114789
Board of directors
-
Abraham Bassan · DirectorSince 2025
-
Andrew Farquharson · DirectorSince 2023
-
Dennis A. Ausiello · DirectorSince 2023
-
Jean Luc Butel · DirectorSince 2023
-
Laureen Debuono · DirectorSince 2023
-
Lisa Ann Rometty · DirectorSince 2023
-
Maulik Nanavaty · DirectorSince 2023
-
Michelle Gilson · DirectorSince 2026
-
Mir A. Imran · DirectorSince 2023
-
Talat Imran · Director · Chief Executive OfficerSince 2023
-
Vasudev Jaiprakash Bailey · DirectorSince 2025
Chief executives
Director election results
Annual meeting of May 28, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
91.3%
-
98.5%
-
99.6%
-
99.7%
-
99.8%
-
99.8%
-
99.8%
Board connections
3 of this board's directors also sit on 5 other boards. 5 are in the same sector.
-
Alnylam Pharmaceuticals Inc. Same sectorvia Dennis A. Ausiello
-
LENZ Therapeutics Inc. Same sectorvia Abraham Bassan
-
Septerna Inc. Same sectorvia Abraham Bassan
-
Seres Therapeutics Inc. Same sectorvia Dennis A. Ausiello
-
Takeda Pharmaceutical Company Limited Same sectorvia Jean Luc Butel
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $50,040
- 2 purchases by 2 insiders
- Sold, last 12 months
- $301
- 1 sale by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 27, 2026 | Talat Imran Director, Officer (Chief Executive Officer) | Shares withheld for tax | −7,928 | $0.76 | $6,025 |
| Sep 27, 2026 | Javadi Alireza Officer (Chief Technical Officer) | Shares withheld for tax | −309 | $0.76 | $235 |
| Jul 21, 2026 | Mir A. Imran Director, 10% owner | Open-market purchase | +36,000 | $0.69 | $24,840 |
| Jul 17, 2026 | Talat Imran Director, Officer (Chief Executive Officer) | Open-market purchase | +35,000 | $0.72 | $25,200 |
| Jun 27, 2026 | Javadi Alireza Officer (Chief Technical Officer) | Shares withheld for tax | −309 | $0.74 | $229 |
| Jun 27, 2026 | Talat Imran Director, Officer (Chief Executive Officer) | Shares withheld for tax | −7,927 | $0.74 | $5,866 |
| Mar 27, 2026 | Javadi Alireza Officer (Chief Technical Officer) | Open-market sale | −386 | $0.78 | $301 |
| Mar 27, 2026 | Talat Imran Director, Officer (Chief Executive Officer) | Shares withheld for tax | −9,099 | $0.81 | $7,370 |
| Mar 22, 2026 | Talat Imran Director, Officer (Chief Executive Officer) | Shares withheld for tax | −8,916 | $1.13 | $10,075 |
| Dec 27, 2025 | Talat Imran Director, Officer (Chief Executive Officer) | Shares withheld for tax | −7,906 | $1.40 | $11,068 |
| Oct 23, 2025 | Mir A. Imran Director, 10% owner | Open-market purchase | +2,083,334 | $0.61 | $1,270,834 |
| Oct 21, 2025 | South Cone Investments Limited Partnership 10% owner | Open-market sale | −4,000,000 | $2.77 | $11,080,000 |
| Oct 20, 2025 | South Cone Investments Limited Partnership 10% owner | Open-market sale | −1,923,000 | $2.41 | $4,634,430 |
| Sep 27, 2025 | Talat Imran Director, Officer (Chief Executive Officer) | Shares withheld for tax | −9,077 | $0.48 | $4,357 |
| Jun 27, 2025 | Talat Imran Director, Officer (Chief Executive Officer) | Shares withheld for tax | −9,076 | $0.55 | $4,992 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Rani Therapeutics Holdings Inc.
Who is the CEO of Rani Therapeutics Holdings Inc.?
Talat Imran is Rani Therapeutics Holdings Inc.'s CEO.
How many directors are on Rani Therapeutics Holdings Inc.'s board?
Rani Therapeutics Holdings Inc.'s board has 11 directors: Abraham Bassan, Andrew Farquharson, Dennis A. Ausiello, Jean Luc Butel, Laureen Debuono, Lisa Ann Rometty, Maulik Nanavaty, Michelle Gilson, Mir A. Imran, Talat Imran and 1 other.
Are Rani Therapeutics Holdings Inc. insiders buying or selling shares?
Over the last 12 months, Rani Therapeutics Holdings Inc. insiders bought $50,040 of shares in 2 purchases and sold $301 of shares in 1 sale on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="rani-therapeutics-holdings-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.